The title of the lecture is;
VALVAX: Evaluating the Long-Run Socioeconomic Effects of Childhood Vaccination
Abstract: This paper studies how the Salk vaccine trial broadly affected public health during the 1950s and 1960s. Involving over 1.8 million child participants, the Salk trial is one of the largest vaccine trials ever conducted. This trial provided access to the inactivated polio vaccine (IPV), established vaccination programs in schools, and provided many parents information about the safety and benefits of childhood vaccination. A growing clinical literature into the secondary “non-specific" effects of vaccines suggests that vaccines can broadly affect overall mortality risk and resistance towards unrelated infections. This paper finds that mortality rates declined substantially in the years following the trials and these mortality reductions exceed what can be explained by decreases in polio alone.
Note: This project has received funding from the European Union's Horizon 2020 research innovation program under grant agreement Marie Skłodowska-Curie Action 2021-2023. No. 890475. Additional support came from the US social Security Administration through the National Bureau of Economic Research's Disability Research Center as part of a NBER Post-Doctoral Fellowship from 2018-2019.
For additional information and information about registration please contact Lars Henrik Pedersen.